{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:14:55Z","timestamp":1760523295924},"reference-count":53,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/or.2015.4016","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T13:18:24Z","timestamp":1432819104000},"page":"555-566","source":"Crossref","is-referenced-by-count":17,"title":["HtrA1: Its future potential as a novel biomarker for cancer"],"prefix":"10.3892","volume":"34","author":[{"given":"EMMA","family":"ALTOBELLI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANIELA","family":"MARZIONI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AMEDEO","family":"LATTANZI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAOLO MATTEO","family":"ANGELETTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"key":"key20180107212312_b1-or-34-02-0555","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(96)01229-X","article-title":"Primary structure of a putative serine protease specific for IGF-binding proteins","volume":"398","author":"Zumbrunn","year":"1996","journal-title":"FEBS Lett"},{"key":"key20180107212312_b2-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/002215540305101004","article-title":"Distribution of the serine protease HtrA1 in normal human tissues","volume":"51","author":"De Luca","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"key20180107212312_b3-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1242\/dev.00999","article-title":"HtrA1 serine protease inhibits signaling mediated by TGF beta family proteins","volume":"131","author":"Oka","year":"2004","journal-title":"Development"},{"key":"key20180107212312_b4-or-34-02-0555","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.0501823102","article-title":"Implications of the serine protease HtrA1 in amyloid precursor protein processing","volume":"102","author":"Grau","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212312_b5-or-34-02-0555","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"key":"key20180107212312_b6-or-34-02-0555","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1074\/jbc.M500361200","article-title":"The role of human HtrA1 in arthritic disease","volume":"281","author":"Grau","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107212312_b7-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.placenta.2012.09.011","article-title":"Alterations of maternal plasma HTRA1 level in preeclampsia complicated by IUGR","volume":"33","author":"Marzioni","year":"2012","journal-title":"Placenta"},{"key":"key20180107212312_b8-or-34-02-0555","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1038\/sj.onc.1205911","article-title":"The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells","volume":"21","author":"Baldi","year":"2002","journal-title":"Oncogene"},{"key":"key20180107212312_b9-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2217\/14622416.9.8.1069","article-title":"The serine protease HtrA1 is a novel prognostic factor for human mesothelioma","volume":"9","author":"Baldi","year":"2008","journal-title":"Pharmacogenomics"},{"key":"key20180107212312_b10-or-34-02-0555","first-page":"508","article-title":"Serine protease HtrA1 expression in human hepatocellular carcinoma","volume":"9","author":"Zhu","year":"2010","journal-title":"Hepatobiliary Panceat Dis Int"},{"key":"key20180107212312_b11-or-34-02-0555","doi-asserted-by":"crossref","first-page":"e60359","DOI":"10.1371\/journal.pone.0060359","article-title":"Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer","volume":"8","author":"Lehner","year":"2013","journal-title":"PLoS One"},{"key":"key20180107212312_b12-or-34-02-0555","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2559.2011.03818.x","article-title":"HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer","volume":"58","author":"Catalano","year":"2011","journal-title":"Histopathology"},{"key":"key20180107212312_b13-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI27698","article-title":"Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity","volume":"116","author":"Chien","year":"2006","journal-title":"J Clin Invest"},{"key":"key20180107212312_b14-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key20180107212312_b15-or-34-02-0555","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.1302700","article-title":"The inhibitory effect of IFN-\u03b3 on protease HTRA1 expression in rheumatoid arthritis","volume":"193","author":"Hou","year":"2014","journal-title":"J Immunol"},{"key":"key20180107212312_b16-or-34-02-0555","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1093\/hmg\/dds225","article-title":"Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3","volume":"21","author":"Cipriani","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key20180107212312_b17-or-34-02-0555","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/1479-7364-5-6-538","article-title":"Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration","volume":"5","author":"Morrison","year":"2011","journal-title":"Hum Genomics"},{"key":"key20180107212312_b18-or-34-02-0555","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/hmg\/ddr270","article-title":"Common variants near FRK\/COL10A1 and VEGFA are associated with advanced age-related macular degeneration","volume":"20","author":"Yu","year":"2011","journal-title":"Hum Mol Genet"},{"key":"key20180107212312_b19-or-34-02-0555","first-page":"1213","article-title":"Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases","volume":"24","author":"Marzioni","year":"2009","journal-title":"Histol Histopathol"},{"key":"key20180107212312_b20-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1541-7786.MCR-09-0473","article-title":"The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein","volume":"8","author":"Campioni","year":"2010","journal-title":"Mol Cancer Res"},{"key":"key20180107212312_b21-or-34-02-0555","first-page":"974","article-title":"Electroporation as a strategy to promote HtrA1 gene uptake and chemotherapy efficacy in a mouse model of mesothelioma","volume":"5","author":"Spugnini","year":"2013","journal-title":"Front Biosci (Elite Ed)"},{"key":"key20180107212312_b22-or-34-02-0555","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18388\/abp.2008_3123","article-title":"Changes in expression of serine proteases HtrA1 and HtrA2 during estrogen-induced oxidative stress and nephrocarcinogenesis in male Syrian hamster","volume":"55","author":"Zurawa-Janicka","year":"2008","journal-title":"Acta Biochim Pol"},{"key":"key20180107212312_b23-or-34-02-0555","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1158\/1078-0432.CCR-06-1056","article-title":"Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma","volume":"12","author":"Spugnini","year":"2006","journal-title":"Clinic Cancer Res"},{"key":"key20180107212312_b24-or-34-02-0555","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.bbrc.2014.03.017","article-title":"Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics","volume":"446","author":"Sahasrabuddhe","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107212312_b25-or-34-02-0555","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnen\/63.3.210","article-title":"Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility","volume":"63","author":"Tatenhorst","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20180107212312_b26-or-34-02-0555","doi-asserted-by":"crossref","first-page":"e39446","DOI":"10.1371\/journal.pone.0039446","article-title":"Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"key20180107212312_b27-or-34-02-0555","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/0008-5472.CAN-09-3557","article-title":"Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells","volume":"70","author":"He","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107212312_b28-or-34-02-0555","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jcb.21804","article-title":"Intracellular localization of the tumor suppressor HtrA1\/Prss11 and its association with HPV16 E6 and E7 proteins","volume":"105","author":"Clawson","year":"2008","journal-title":"J Cell Biochem"},{"key":"key20180107212312_b29-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.onc.1207271","article-title":"A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer","volume":"23","author":"Chien","year":"2004","journal-title":"Oncogene"},{"key":"key20180107212312_b30-or-34-02-0555","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1600-0625.2003.00026.x","article-title":"Identification of genes down-regulated during melanoma progression: a cDNA array study","volume":"12","author":"Baldi","year":"2003","journal-title":"Exp Dermatol"},{"key":"key20180107212312_b31-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.ajpath.2013.02.003","article-title":"The emerging roles of HTRA1 in musculoskeletal disease","volume":"182","author":"Tiaden","year":"2013","journal-title":"Am J Pathol"},{"key":"key20180107212312_b32-or-34-02-0555","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1381612811319060003","article-title":"HtrA protease family as therapeutic targets","volume":"19","author":"Skorko-Glonek","year":"2013","journal-title":"Curr Pharm Des"},{"key":"key20180107212312_b33-or-34-02-0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.abb.2011.10.007","article-title":"The structural basis of mode of activation and functional diversity: a case study with HtrA family of serine proteases","volume":"516","author":"Singh","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"key20180107212312_b34-or-34-02-0555","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/14728222.2010.487867","article-title":"HtrA proteins as targets in therapy of cancer and other diseases","volume":"14","author":"Zurawa-Janicka","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107212312_b35-or-34-02-0555","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-59745-390-5_13","article-title":"Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis","volume":"377","author":"MacDonald","year":"2007","journal-title":"Methods Mol Biol"},{"key":"key20180107212312_b36-or-34-02-0555","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800909788486704","article-title":"HtrA serine proteases as potential therapeutic targets in cancer","volume":"9","author":"Chien","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107212312_b37-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/jcb.24751","article-title":"HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties","volume":"115","author":"Xu","year":"2014","journal-title":"J Cell Biochem"},{"key":"key20180107212312_b38-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/1055-9965.EPI-10-1336","article-title":"Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers","volume":"20","author":"Neuhausen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107212312_b39-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ijc.26044","article-title":"HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation","volume":"130","author":"He","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180107212312_b40-or-34-02-0555","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1158\/1078-0432.CCR-04-0548","article-title":"Gene expression profile associated with response to doxorubicin-based therapy in breast cancer","volume":"11","author":"Folgueira","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107212312_b41-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1590\/S0100-879X2010007500135","article-title":"Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients","volume":"43","author":"Barros Filho","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"key20180107212312_b42-or-34-02-0555","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-014-1387-4","article-title":"Expression and localization of serine protease Htra1 in neuroblastoma: correlation with cellular differentiation grade","volume":"117","author":"D\u2019Angelo","year":"2014","journal-title":"J Neurooncol"},{"key":"key20180107212312_b43-or-34-02-0555","first-page":"2650","article-title":"HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker","volume":"133","author":"Lorenzi","year":"2013","journal-title":"Int J Cancer"},{"key":"key20180107212312_b44-or-34-02-0555","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1477-7819-10-179","article-title":"HtrA1 expression associated with the occurrence and development of esophageal cancer","volume":"10","author":"Yu","year":"2012","journal-title":"World J Surg Oncol"},{"key":"key20180107212312_b45-or-34-02-0555","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13277-012-0553-6","article-title":"Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-\u03baB signaling pathway","volume":"34","author":"Xia","year":"2013","journal-title":"Tumor Biol"},{"key":"key20180107212312_b46-or-34-02-0555","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1158\/1078-0432.CCR-09-3069","article-title":"Expression and functional significance of HtrA1 loss in endometrial cancer","volume":"17","author":"Mullany","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107212312_b47-or-34-02-0555","first-page":"1529","article-title":"Expression of human HtrA1, HtrA2, HtrA3 and TGF-beta1 genes in primary endometrial cancer","volume":"21","author":"Narkiewicz","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107212312_b48-or-34-02-0555","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2006.03.006","article-title":"Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer","volume":"103","author":"Bowden","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180107212312_b49-or-34-02-0555","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3892\/or.2012.1988","article-title":"Changes in expression of human serine protease HtrA1, HtrA2 and HtrA3 genes in benign and malignant thyroid tumors","volume":"28","author":"Zurawa-Janicka","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107212312_b50-or-34-02-0555","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.clinbiochem.2008.01.004","article-title":"Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer","volume":"41","author":"Narkiewicz","year":"2008","journal-title":"Clin Biochem"},{"key":"key20180107212312_b51-or-34-02-0555","first-page":"3455","article-title":"Analysis of HtrA1 serine protease expression in human lung cancer","volume":"26","author":"Esposito","year":"2006","journal-title":"Anticancer Res"},{"key":"key20180107212312_b52-or-34-02-0555","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2014.08.013","article-title":"Genomic aspects of age-related macular degeneration","volume":"452","author":"Horie-Inoue","year":"2014","journal-title":"Biochem Biophysis Res Commun"},{"key":"key20180107212312_b53-or-34-02-0555","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ypmed.2014.02.010","article-title":"Colorectal cancer prevention in Europe: burden of disease and status of screening programs","volume":"62","author":"Altobelli","year":"2014","journal-title":"Prev Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4016\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:35:46Z","timestamp":1599075346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,5,28]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/or.2015.4016"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4016","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]}}}